Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
27.18
-0.39 (-1.41%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Tango Therapeutics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Tango Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $44.33. The average 1-year stock price forecast is 63.10% higher than the current stock price, while the lowest is $24 (-11.70%) and the highest is $69 (+153.86%).
Price Target: $44.33 (+63.10%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tango Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 9 | 11 | 11 |
| Buy | 1 | 1 | 1 | 0 | 0 | 1 |
| Hold | 1 | 1 | 1 | 3 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $46 | Buy | Maintains | $46 | +69.24% | Jul 30, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $36 → $40 | Buy | Maintains | $36 → $40 | +47.17% | Jul 17, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $46 | Buy | Initiates | $46 | +69.24% | Jul 15, 2026 |
| Jefferies | Jefferies | Buy Upgrades $60 | Buy | Upgrades | $60 | +120.75% | Jun 25, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $32 | Buy | Maintains | $32 | +17.73% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
n/a
from 62.38M
Decreased by -100.00%
Revenue Next Year
2.86M
EPS This Year
-1.29
from -0.87
EPS Next Year
-1.52
from -1.29
EPS and Forward PE are based on non-GAAP adjusted numbers.